arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

iRhythm Holdings, Inc.

IRTC Health Care Medical/Dental Instruments
$123.07
Today
as of Sep 4, 16:50 ET
Last 30 days +4.86% Jul 28 → Sep 04
$114.18 $118.03 $121.88 $125.73 $129.58 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$121.47
High
$123.52
Low
$120.61
Volume
$444,467
Avg Vol
$548,241
Mkt Cap
$4.2B
P/E (TTM)
—
Beta
—
52w High
$212.00
52w Low
$100.85
Div Yield
—
Shares Out
$33M

Recent Press Releases & News last 60 days · 22 items

Sep 4 · 15:12 Zacks
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
Aug 26 · 20:05 PR GlobeNewswire
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
Aug 26 · 03:09 Simply Wall St.
iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds
▸ Show all 22 press releases & news Free account →

Overview

52-week range
$101
$212
20% of range
Avg surprise (last 2)
+16.4%
Avg reaction (last 1)
+1.6%
100% positive
Latest IV / EM
41%
EM ±6.3% · $125 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.48$-1.11$-0.74$-0.38$-0.01 Actual $-1.29Actual $-0.61Actual $-0.89Actual $-1.47Actual $-0.65Actual $-1.48Actual $-0.95Est $-0.89Actual $-0.32Est $-0.53Actual $-0.16Actual $-0.43Actual $-0.01 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$-46M$24M$95M$165M$235M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.01 — — — — financials
Tue Mar 31, 2026Mar 2026 $-0.43 — — — — financials
Tue Sep 30, 2025Sep 2025 $-0.16 — — — — financials
Thu Jul 31, 2025Jun/2025 $-0.32 $-0.53 +39.6% — — earnings
Thu May 1, 2025Mar/2025 $-0.95 $-0.89 -6.7% — +1.6% earnings
Mon Sep 30, 2024Sep 2024 $-1.48 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.65 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.47 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.89 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.61 — — — — financials
Fri Mar 31, 2023Mar 2023 $-1.29 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$224M$199M—$193M$187M$159M—$148M
Cost of revenue$61M$58M—$56M$54M$49M—$46M
Gross profit$163M$141M—$137M$133M$109M—$101M
Operating income$-3M$-16M—$-8M$-19M$-33M—$-50M
Net income$-381,000$-14M—$-5M$-14M$-31M—$-46M
EPS (diluted)$-0.01$-0.43—$-0.16$-0.44$-0.97—$-1.48

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$247M$240M$236M$256M$309M$375M$420M$520M
Inventory$23M$24M$22M$20M$18M$14M$14M$15M
Total current assets$756M$681M$703M$680M$664M$636M$646M$628M
Total assets$1.09B$1.01B$1.02B$995M$964M$926M$931M$910M
Long-term debt————————
Total liabilities$907M$845M$867M$873M$860M$839M$841M$838M
Total equity$186M$161M$153M$122M$104M$87M$91M$72M

Implied volatility — last 90 days

40%57%73%90%106% Jun 07 — IV 64% · EM ±8.9%Jun 08 — IV 57% · EM ±7.5%Jun 09 — IV 55% · EM ±6.9%Jun 10 — IV 56% · EM ±6.6%Jun 11 — IV 59% · EM ±6.5%Jun 12 — IV 50% · EM ±5.1%Jun 15 — IV 67% · EM ±4.8%Jun 16 — IV 77% · EM ±4.5%Jun 17 — IV 89% · EM ±3.7%Jun 19 — IV 51% · EM ±11.3%Jun 22 — IV 51% · EM ±10.6%Jun 23 — IV 51% · EM ±10.4%Jun 24 — IV 51% · EM ±10.2%Jun 25 — IV 53% · EM ±10.3%Jun 26 — IV 50% · EM ±9.5%Jun 29 — IV 51% · EM ±9.0%Jun 30 — IV 53% · EM ±9.1%Jul 01 — IV 50% · EM ±8.4%Jul 02 — IV 46% · EM ±7.5%Jul 03 — IV 48% · EM ±7.5%Jul 06 — IV 54% · EM ±7.5%Jul 07 — IV 47% · EM ±6.2%Jul 08 — IV 52% · EM ±6.5%Jul 09 — IV 57% · EM ±6.7%Jul 10 — IV 45% · EM ±5.0%Jul 13 — IV 71% · EM ±5.9%Jul 14 — IV 71% · EM ±5.1%Jul 15 — IV 81% · EM ±4.8%Jul 16 — IV 73% · EM ±3.1%Jul 20 — IV 61% · EM ±14.5%Jul 21 — IV 65% · EM ±15.2%Jul 22 — IV 61% · EM ±13.9%Jul 23 — IV 61% · EM ±13.7%Jul 24 — IV 62% · EM ±13.6%Jul 27 — IV 67% · EM ±14.0%Jul 28 — IV 62% · EM ±12.7%Jul 29 — IV 66% · EM ±13.3%Jul 30 — IV 70% · EM ±13.8%Jul 31 — IV 65% · EM ±12.5%Aug 03 — IV 69% · EM ±12.2%Aug 04 — IV 74% · EM ±12.7%Aug 05 — IV 70% · EM ±11.7%Aug 06 — IV 65% · EM ±10.6%Aug 07 — IV 51% · EM ±8.0%Aug 10 — IV 49% · EM ±6.7%Aug 11 — IV 49% · EM ±6.5%Aug 12 — IV 48% · EM ±6.1%Aug 13 — IV 45% · EM ±5.3%Aug 14 — IV 48% · EM ±5.3%Aug 17 — IV 55% · EM ±4.6%Aug 18 — IV 53% · EM ±3.8%Aug 19 — IV 63% · EM ±3.7%Aug 20 — IV 107% · EM ±4.5%Aug 24 — IV 46% · EM ±9.5%Aug 25 — IV 43% · EM ±8.9%Aug 26 — IV 45% · EM ±9.0%Aug 27 — IV 45% · EM ±8.8%Aug 28 — IV 46% · EM ±8.9%Aug 31 — IV 49% · EM ±8.7%Sep 01 — IV 48% · EM ±8.3%Sep 02 — IV 47% · EM ±7.8%Sep 03 — IV 49% · EM ±8.0%Sep 04 — IV 41% · EM ±6.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in